Interaction of cationic peptides with lipoteichoic acid and gram- positive bacteria

Infection and Immunity

Volumn 67, Issue 12, 1999, Pages 6445-6453

  Scott, Monisha G ^a   Gold, Michael R ^a   Hancock, Robert E W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; LIPOTEICHOIC ACID; PEPTIDE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIMICROBIAL ACTIVITY; ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG BINDING; GRAM POSITIVE BACTERIUM; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; SEPSIS; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CARRIER PROTEINS; CATIONS; CELL LINE; ESCHERICHIA COLI; GRAM-POSITIVE BACTERIA; HUMANS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MICROBIAL SENSITIVITY TESTS; PEPTIDES; RECOMBINANT PROTEINS; STAPHYLOCOCCUS AUREUS; TEICHOIC ACIDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032752132     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Boman, H. G., D. Wade, I. A. Boman, B. Wahlin, and K. B. Merrifield. 1989. Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids. FEBS Lett. 259:103-106.
2. Bone, R. C. 1994. Gram-positive organisms and sepsis. Arch. Intern. Med. 154:26-34.
3. De Kimpe, S. J., M. Kengatharan, C. Thiemermann, and J. R. Vane. 1995. The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc. Natl. Acad. Sci. USA 92:10359-10363.
4. Dziarski, R., R. I. Tapping, and P. S. Tobias. 1998. Binding of bacterial peptidoglycan to CD14. J. Biol. Chem. 273:8680-8690.
5. English, B. K., C. C. Patrick, S. L. Orlicek, R. McCordic, and J. L. Shenep. 1996. Lipoteichoic acid from viridans streptococci induces the production of tumor necrosis factor and nitric oxide by murine macrophages. J. Infect. Dis. 174:1348-1351.
6. Fischer, W. 1988. Physiology of lipoteichoic acids in bacteria. Adv. Microb. Physiol. 29:233-302.
7. Fischer, W., T. Mannsfeld, and G. Hagen. 1990. On the basic structure of poly(glycerophosphate) lipoteichoic acids. Biochem. Cell Biol. 68:33-43.
8. Gough, M., R. E. W. Hancock, and N. M. Kelly. 1996. Antiendotoxin activity of cationic peptide antimicrobial agents. Infect. Immun. 64:4922-4927.
9. Grunfeld, C., M. Marshall, J. K. Shigenaga, A. H. Moser, P. Tobias, and K. R. Feingold. 1999. Lipoproteins inhibit macrophage activation by lipoteichoic acid. J. Lipid Res. 40:245-252.
10. Heumann, D., C. Barras, A. Severin, M. P. Glauser, and A. Tomasz. 1994. Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect. Immun. 62:2715-2721.
11. Heumann, D., M. P. Glauser, and T. Calandra. 1998. Molecular basis of host-pathogen interaction in septic shock. Curr. Opin. Microbiol. 1:49-55.
12. Horne, D., and A. Tomasz. 1979. Release of lipoteichoic acid from Streptococcus sanguis: stimulation of release during penicillin treatment. J. Bacteriol. 137:1180-1184.
13. Kelly, N. M., L. Young, and A. S. Cross. 1991. Differential induction of tumor necrosis factor by bacteria expressing rough and smooth lipopolysaccharide phenotypes. Infect. Immun. 59:4491-4496.
14. Kengatharan, K. M., S. De Kimpe, C. Robson, S. J. Foster, and C. Thiermermann. 1998. Mechanism of gram-positive shock: identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock, and multiple organ failure. J. Exp. Med. 188:305-315.
15. Le Roy, D., P. Morand, S. Lengacher, M. Celio, G. E. Grau, M. P. Glauser, and D. Heumann. 1996. Streptococcus mitis cell walls and lipopolysaccharide induce lethality in D-galactosamine-sensitized mice by a tumor necrosis factor-dependent pathway. Infect. Immun. 64:1846-1849.
16. Mattsson, E., J. Rollof, J. Verhoef, H. Van Dijk, and A. Fleer. 1994. Serum-induced potentiation of tumor necrosis factor alpha production by human monocytes in response to staphylococcal peptidoglycan: involvement of different serum factors. Infect. Immun. 62:3837-3843.
17. Moore, R. A., N. C. Bates, and R. E. W. Hancock. 1986. Interaction of polycationic antibiotics with Pseudomonas aeruginosa lipopolysaccharide and lipid A studied by using dansyl-polymyxin. Antimicrob. Agents Chemother. 29:496-500.
18. Natanson, C., R. L. Danner, R. J. Elin, J. M. Hosseini, K. W. Peart, S. M. Banks, T. J. MacVittie, R. I. Walker, and J. E. Parrillo. 1989. Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock. J. Clin. Investig. 83:243-151. (Erratum, 83:1087.)
19. Piers, K. L., M. H. Brown, and R. E. W. Hancock. 1994. Improvement of outer membrane-permeabilizing and lipopolysaccharide-binding activities of an antimicrobial cationic peptide by C-terminal modification. Antimicrob. Agents Chemother. 38:2311-2316.
20. Rocque, W. J., S. W. Fesik, A. Haug, and E. J. McGroarty. 1988. Polycation binding to isolated lipopolysaccharide from antibiotic-hypersusceptible mutant strains of Escherichia coli. Antimicrob. Agents Chemother. 32:308-313.
21. Rogy, M. A., L. L. Moldawer, H. S. Oldenburg, W. A. Thompson, W. J. Montegut, S. A. Stackpole, A. Kumar, M. A. Palladino, M. N. Marra, and S. F. Lowry. 1994. Anti-endotoxin therapy in primate bacteremia with HA-1A and BPI. Ann. Surg. 220:77-85.
22. Scott, M. G., H. Yan, and R. E. W. Hancock. 1999. Biological properties of structurally related α-helical cationic antimicrobial peptides. Infect. Immun. 67:2005-2009.
23. Soell, M., M. Diab, G. Haan-Archipoff, A. Beretz, C. Herbelin, B. Poutrel, and J.-P. Klein. 1995. Capsular polysaccharide types 5 and 8 of Staphylococcus aureus bind specifically to human epithelial (KB) cells, endothelial cells, and monocytes and induce release of cytokines. Infect. Immun. 63:1380-1386.
24. Soell, M., E. Lett, F. Holveck, M. Scholler, D. Wachsmann, and J.-P. Klein. 1995. Activation of human monocytes by streptococcal rhamnose glucose polymers is mediated by CD14 antigen, and mannan binding protein inhibits TNF-α release. J. Immunol. 154:851-860.
25. Solo, A., T. J. Evans, and J. Cohen. 1996. Proinflammatory cytokine production by human peripheral blood mononuclear cells stimulated with cell-free supernatants of viridans streptococci. Cytokine 8:300-304.
26. Takada, H., Y. Kawabata, S. Kawata, and S. Kusomoto. 1996. Structural characteristics of peptidoglycan fragments required to prime mice for induction of anaphylactoid reactions by lipopolysaccharides. Infect. Immun. 64: 657-659.
27. Ulevitch, R. J., and P. S. Tobias. 1995. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13:437-457.
28. Ulevitch, R. J., and P. S. Tobias. 1999. Recognition of gram-negative bacteria and endotoxin by the innate immune system. Curr. Opin. Immunol. 11:19-22.
29. van Langevelde, P., J. T. van Dissel, E. Ravensbergen, B. J. Appelmelk, I. A. Schrijver, and P. H. P. Groeneveld. 1998. Antibiotic-induced release of lipoteichoic acid and peptidoglycan from Staphylococcus aureus: quantitative measurements and biological reactivities. Antimicrob. Agents Chemother. 42:3073-3078.
30. Van Zee, K. J., L. L. Moldawer, H. S. Oldenburg, W. A. Thompson, S. A. Stackpole, W. J. Montegut, M. A. Rogy, C. Meschter, H. Gallati, C. D. Schiller, W. F. Richter, H. Loetscher, A. Ashkenazi, S. M. Chamow, F. Wurm, S. E. Calvano, S. F. Lowry, and W. Lesslauer. 1996. Protection against lethal Escherichia coli bacteremia in baboons (Papio anubis) by pretreatment with a 55-kDa TNF receptor (CD120a)-Ig fusion protein, Ro 45-2081. J. Immunol. 156:2221-2230.
31. Wakabayashi, G., J. A. Gelfand, W. K. Jung, R. J. Connolly, J. F. Burke, and C. A. Dinarello. 1991. Staphylococcus epidemidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli. J. Clin. Investig. 87:1925-1935.
32. Weidemann, B., J. Schletter, R. Dziarski, S. Kusumoto, F. Stelter, E. T. Rietschel, H.-D. Flad, and A. J. Ulmer. 1997. Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes. Infect. Immun. 65:858-864.
33. Wu, M., and R. E. W. Hancock. 1999. Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane. J. Biol. Chem. 274:29-35.